Parkinson’s Disease stem cells

FDA cautions R3 Stem Cell & 50+ stem cell clinic affiliates

R3-Stem-Cell-testimonials

Today the FDA put an Arizona firm called R3 Stem Cell, LLC and its leader Dr. David Greene on notice that what they and 50+ affiliates centers are selling in the way of stem cells were not approved by the agency. R3 Stem Cell markets perinatal (birth-related) stem cell offerings on its website. There’s a …

FDA cautions R3 Stem Cell & 50+ stem cell clinic affiliates Read More »

Guest Post from Jeanne Loring: Patients talk stem cells. The FDA listens.

Jenifer-Raub

By Jeanne Loring Last Tuesday I visited the FDA headquarters in Maryland, for a meeting called Public Meeting on Patient-Focused Drug Development for Huntington’s and Parkinson’s Diseases. The FDA holds about 6 meetings on different diseases each year, inviting patients and advocates to speak while a panel of FDA directors listens. The FDA representatives at …

Guest Post from Jeanne Loring: Patients talk stem cells. The FDA listens. Read More »

Michael Cea ISSCR chat with Jeanne Loring on stem cell field

Lewy_Body_alphaSynuclein

By Michael Cea Jeanne Loring of the Scripps Research Institute in La Jolla, California kindly sat down with me at the ISSCR annual meeting for a broad discussion of her history, views on the field and developments in the science. I found Jeanne a refreshing character, as I did a number of others I was fortunate to …

Michael Cea ISSCR chat with Jeanne Loring on stem cell field Read More »

My new ‘neighbor’ in Sacramento: a fat stem cell clinic

Thomas-A.-Glonis1

For years I’ve been writing about fat stem cell clinics that sell non-FDA approved stem cell “treatments” to vulnerable patients right here in America. These clinics have been sprouting up like mushrooms across the US and their numbers may be above 200 today overall. As a result perhaps it was inevitable that one would arrive in …

My new ‘neighbor’ in Sacramento: a fat stem cell clinic Read More »

Yamanaka Interview on Clinical Use of IPSC

Dr.-ShinyaYamanaka

I invited Nobel Laureate Shinya Yamanaka to do an interview on the future of clinical translation of induced pluripotent stem cells (iPSC). He provides some intriguing new insights into the iPSC field and the broader stem cell arena. PK: The Takahashi Team’s active Clinical Study using iPSCs to make RPEs to treat Macular Degeneration has …

Yamanaka Interview on Clinical Use of IPSC Read More »

Will Speedy A4M Stem Cell Course for Docs Put Patients at Risk?

A4M-logo

They say a little knowledge is a dangerous thing and more specifically I say that a little stem cell training for MDs, such as from A4M, can potentially be a dangerous problem too. I’ve been very concerned about self-proclaimed “stem cell training courses” for MDs. These kinds of courses have claimed that over as short as a …

Will Speedy A4M Stem Cell Course for Docs Put Patients at Risk? Read More »

Trial of Stem Cells for Parkinson’s Disease on Horizon

Is a treatment based on stem cells for Parkinson’s Disease on the horizon? A Japanese team of researchers led by Dr. Jun Takahashi, professor at Kyoto University is reportedly aiming to start on human studies of an induced pluripotent stem (iPS) cell-based treatment for Parkinson’s Disease (PD) as early as fiscal year (FY) 2014. In …

Trial of Stem Cells for Parkinson’s Disease on Horizon Read More »